Video Experimental Relacionado
Updated: Feb 1, 2026
07:13
A Rat Model of Pressure Overload Induced Moderate Remodeling and Systolic Dysfunction as Opposed to Overt Systolic Heart Failure
Published on: April 30, 2020
6.9K
Alteraciones celulares en el hueso trabecular tras insuficiencia cardíaca derecha inducida por monocrotalina en ratas
Akinori Kaneguchi1, Rena Takagi1, Sakura Sunagawa1
1Department of Rehabilitation, Faculty of Rehabilitation, Hiroshima International University, Kurose-Gakuendai 555-36, Higashi-Hiroshima, Hiroshima, Japan.
Bone
|January 30, 2026
Resumen
La insuficiencia cardíaca provoca el deterioro óseo al aumentar la actividad de los osteoclastos y la pérdida de osteocitos (apoptosis). Esto conduce a una reducción del volumen óseo y a un mayor riesgo de fractura en los pacientes, lo que pone de relieve una preocupación clínica crítica.
Área de la Ciencia:
- Biología ósea
- Enfermedad cardiovascular
- Patología celular
Sus antecedentes:
- La insuficiencia cardíaca se asocia con el deterioro óseo y un mayor riesgo de fractura.
- Las fracturas en pacientes con insuficiencia cardíaca se correlacionan con una mayor hospitalización y mortalidad.
- Los mecanismos celulares de la pérdida ósea relacionada con la insuficiencia cardíaca no se comprenden bien.
Objetivo del estudio:
- Investigar los cambios histológicos en el hueso trabecular después de inducir insuficiencia cardíaca.
- Caracterizar las alteraciones celulares que contribuyen al deterioro óseo en la insuficiencia cardíaca.
Principales métodos:
- Se dividieron ratas Wistar macho en grupos de control e insuficiencia cardíaca.
- Se indujo insuficiencia cardíaca mediante monocrotalina; los controles recibieron una inyección de vehículo.
- Se realizaron análisis histológicos del hueso (húmero, fémur, tibia) 28 días después de la inyección.
Principales resultados:
- Las ratas con insuficiencia cardíaca mostraron un volumen óseo trabecular significativamente reducido en todos los sitios.
- Se observó un aumento en el número de osteoclastos y la proporción de lacunas vacías (pérdida de osteocitos).
- Una mayor proporción de osteocitos positivos a caspasa-3 indicó un aumento de la apoptosis.
Conclusiones:
- La insuficiencia cardíaca induce la apoptosis de los osteocitos, lo que podría impulsar la osteoclastogénesis y la pérdida ósea.
- Los cambios consistentes en todos los sitios anatómicos sugieren la participación de factores sistémicos.
- La comprensión de estos mecanismos puede conducir a nuevas terapias para la pérdida ósea relacionada con la insuficiencia cardíaca.
Videos de Conceptos Relacionados
01:29Heart Failure II: Pathophysiology
920
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
920
01:17Pathophysiology of Heart Failure
3.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.6K
01:27Heart Failure I: Introduction
882
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
882
01:22Heart Failure VI: Adjunct Therapies
336
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
336
01:22Heart Failure Drugs: Diuretics
966
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
966
01:30Heart Failure V: Medical Management
312
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
312